作者：
Jamie L,Todd [1]
;
Megan L,Neely [2]
;
Robert,Overton [3]
;
Hillary,Mulder [4]
;
Jesse,Roman [3]
;
Joseph A,Lasky [3]
;
Joao A,de Andrade [5]
;
Mridu,Gulati [6]
;
Howard,Huang [7]
;
Thomas B,Leonard [8]
;
Christian,Hesslinger [9]
;
Imre,Noth [10]
;
John A,Belperio [11]
;
Kevin R,Flaherty [12]
;
Scott M,Palmer [13]
;
IPF-PRO Registry investigators [14]
作者单位：
Duke Clinical Research Institute, DUMC Box 103002, Durham, NC, 27710, USA. jamie.todd@dm.duke.edu.
[1]
Duke University Medical Center, Durham, NC, USA. jamie.todd@dm.duke.edu.
[2]
Duke Clinical Research Institute, DUMC Box 103002, Durham, NC, 27710, USA.
[3]
Duke University Medical Center, Durham, NC, USA.
[4]
Jane and Leonard Korman Respiratory Institute, Philadelphia, PA, USA.
[5]
School of Medicine, Tulane University, New Orleans, LA, USA.
[6]
Vanderbilt University School of Medicine, Nashville, TN, USA.
[7]
Yale School of Medicine, New Haven, CT, USA.
[8]
Houston Methodist Hospital, Houston, TX, USA.
[9]
Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.
[10]
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
[11]
Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA.
[12]
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
[13]
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
[14]
DOI
10.1007/s00408-022-00516-3
PMID
35166906
发布时间
2022-03-28
换一批
换一批
